Thrap3 promotes osteogenesis by inhibiting the degradation of Runx2

FASEB J. 2022 Apr;36(4):e22231. doi: 10.1096/fj.202101706R.

Abstract

The dysfunction of osteogenesis is a key character in the pathogenesis of osteoporosis, but the network of signaling mechanisms in controlling the differentiation of osteoblast remain unclear. Thrap3 has been proved participating in various biological process, especially in the differentiation of stem cells. Here, we demonstrate that Thrap3 could promote osteogenesis through the inhibition of the degradation of Runx2, which is a key molecular structure in early osteoblast differentiation. Furthermore, we found that the osteogenesis enhancing capacity of Thrap3 was caused by physically binding with Sox9, inhibiting the transcriptional activity of Sox9, and then decreasing the decomposition-promoted effect of Sox9 on Runx2. Our data shows that Thrap3 promotes osteoblast differentiation through the Thrap3-Sox9-Runx2 axis. What we found may help for further clarifying the molecular mechanism of osteogenic differentiation and give a new potential therapeutic target for osteoporosis.

Keywords: Runx2; Sox9; Thrap3; osteogenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Differentiation
  • Core Binding Factor Alpha 1 Subunit / antagonists & inhibitors
  • Core Binding Factor Alpha 1 Subunit / physiology*
  • DNA-Binding Proteins / physiology*
  • HEK293 Cells
  • Humans
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Osteoblasts / cytology
  • Osteogenesis / physiology*
  • SOX9 Transcription Factor / physiology
  • Transcription Factors / physiology*

Substances

  • Core Binding Factor Alpha 1 Subunit
  • DNA-Binding Proteins
  • RUNX2 protein, human
  • SOX9 Transcription Factor
  • SOX9 protein, human
  • THRAP3 protein, human
  • Transcription Factors